Similar articles

• [Unexpected sudden death of asthma patients; results of a survey].

  Meyboom RH. Meyboom RH. Ned Tijdschr Geneeskd. 1984 Mar 10;128(10):457-8. Ned Tijdschr Geneeskd. 1984. PMID: 6143268 Dutch. No abstract available.
• [Adrenergic therapy and vigilance: beta-2 sympathomimetic aerosols in asthma].

  Moulin M, Hugues FC, Bigot MC, Mosquet B. Moulin M, et al. Allerg Immunol (Paris). 1988 Oct;20(8):306, 309, 311. Allerg Immunol (Paris). 1988. PMID: 2903751 Review. French.
• [beta-adrenergic agonists and mortality and morbidity in asthma].

  Wever AM, Wever-Hess J. Wever AM, et al. Ned Tijdschr Geneeskd. 1992 Mar 7;136(10):460-5. Ned Tijdschr Geneeskd. 1992. PMID: 1347647 Review. Dutch. No abstract available.
• Risk of death from beta-agonist use is extremely small, meta-analysis shows.

  [No authors listed] [No authors listed] Am J Hosp Pharm. 1994 Jan 1;51(1):13. Am J Hosp Pharm. 1994. PMID: 7907840 No abstract available.
• The use of beta agonists and the risk of death and near death from asthma.

  Pearce N. Pearce N. J Clin Epidemiol. 2009 Jun;62(6):582-7. doi: 10.1016/j.jclinepi.2009.01.004. J Clin Epidemiol. 2009. PMID: 19422997 No abstract available.